Literature DB >> 28944967

Risk for chromosomal aberrations in apparently isolated intrauterine growth restriction: A systematic review.

Lena Sagi-Dain1,2, Amir Peleg1,2, Shlomi Sagi3.   

Abstract

OBJECTIVE: To perform a systematic review examining the risk of chromosomal aberrations in apparently isolated intrauterine growth restriction (IUGR).
METHODS: Search was conducted by research librarian in 5 databases. By independent screening of 2894 references, 2 investigators selected original studies examining the risk of chromosomal aberrations in apparently isolated IUGR diagnosed at the second and third trimesters by using ultrasound. We excluded studies describing IUGR combined with additional fetal anomalies detected by ultrasound and those where fetuses with structural anomalies or aneuploidy were not reported.
RESULTS: Fourteen observational cohort studies were found, encompassing 874 apparently isolated IUGR cases. Mean rate of chromosomal aberrations was 6.4%, ranging between 0% (in 3 studies) and 26.3%. Only 2 articles examined apparently isolated IUGR diagnosed in the third trimester, encompassing a total of 32 pregnancies. Invasive testing of these cases yielded normal karyotypes. A single article analyzed 137 second trimester IUGR pregnancies, reporting 2 abnormal karyotypes of minimal clinical significance. Overall quality of existing evidence was defined as "very low."
CONCLUSIONS: Due to a limited number of cases and insufficient quality of evidence, high-quality well standardized case-controlled trials should be conducted, further exploring the risk for chromosomal aberrations in pregnancies with isolated IUGR.
© 2017 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28944967     DOI: 10.1002/pd.5160

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  6 in total

1.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

2.  The Genetic and Clinical Outcomes in Fetuses With Isolated Fetal Growth Restriction: A Chinese Single-Center Retrospective Study.

Authors:  Hang Zhou; Ken Cheng; Yingsi Li; Fang Fu; Ru Li; Yongling Zhang; Xin Yang; Xiangyi Jing; Fucheng Li; Jin Han; Min Pan; Li Zhen; Dongzhi Li; Can Liao
Journal:  Front Genet       Date:  2022-04-28       Impact factor: 4.772

3.  Fetal phenotypes emerge as genetic technologies become robust.

Authors:  Kathryn J Gray; Louise E Wilkins-Haug; Nancy J Herrig; Neeta L Vora
Journal:  Prenat Diagn       Date:  2019-08-05       Impact factor: 3.050

4.  Prenatal diagnosis of fetal growth restriction with polyhydramnios, etiology and impact on postnatal outcome.

Authors:  Adeline Walter; Elina Calite; Christoph Berg; Ulrich Gembruch; Andreas Müller; Annegret Geipel
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

Review 5.  Genetic Background of Fetal Growth Restriction.

Authors:  Beata Anna Nowakowska; Katarzyna Pankiewicz; Urszula Nowacka; Magdalena Niemiec; Szymon Kozłowski; Tadeusz Issat
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

6.  3q27.1 microdeletion causes prenatal and postnatal growth restriction and neurodevelopmental abnormalities.

Authors:  Subit Barua; Elaine M Pereira; Vaidehi Jobanputra; Kwame Anyane-Yeboa; Brynn Levy; Jun Liao
Journal:  Mol Cytogenet       Date:  2022-03-03       Impact factor: 2.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.